Omi is a mammalian serine protease that is localized in the mitochondria and released to the cytoplasm in response to apoptotic stimuli. Omi induces cell death in a caspase-dependent manner by interacting with the Xchromosome linked inhibitor of apoptosis protein, as well as in a caspase-independent way that relies on its proteolytic activity. Omi is synthesized as a precursor polypeptide and is processed to an active serine protease with a unique PDZ domain. PDZ domains recognize the extreme carboxyl terminus of target proteins. Internal peptides that are able to fold into a b-finger are also reported to bind some PDZ domains. Using a modified yeast two-hybrid system, PDZ Omi mutants were isolated by their ability to bind the carboxyl terminus of human Myc oncoprotein in yeast as well as in mammalian cells. One such PDZ m domain (PDZ-M1), when transfected into mammalian cells, was able to bind to endogenous Myc protein and induce cell death. PDZ-M1-induced apoptosis was entirely dependent on the presence of Myc protein and was not observed when c-myc null fibroblasts were used. Our studies indicate that the PDZ domain of Omi can provide a prototype that could easily be exploited to target specifically and inactivate oncogenes by binding to their unique carboxyl terminus.
Introduction
Omi, also known as HtrA2, is a human serine protease with extensive similarity to bacterial high-temperature requirement A (HtrA) protease (Pallen and Wren, 1997; Faccio et al., 2000b) . Bacterial HtrAs act as chaperones at normal temperatures and as proteases at elevated temperatures to cleave and remove denatured or damaged proteins allowing the survival of bacteria following heat shock and other stress (Pallen and Wren, 1997) . Omi was originally isolated through binding to Mxi2, an alternatively spliced form of p38 stressactivated kinase (SAPK) (Faccio et al., 2000a) . It was subsequently isolated independently as an interactor of presenilin, a protein found mutated in some individuals with Alzheimer's disease (Gray et al., 2000) . Omi is expressed ubiquitously and the amount of protein increases when cells are exposed to heat shock or treated with tunicamycin (Gray et al., 2000) . The proteolytic activity of Omi is also regulated by cellular stress including kidney ischemia/reperfusion (Faccio et al., 2000b) . Recent studies have identified Omi as a mitochondrial protein that is released to the cytoplasm following apoptotic stimuli (Suzuki et al., 2001; Hegde et al., 2002; Martins et al., 2002; Verhagen et al., 2002) . In the cytoplasm, Omi interacts with X-chromosome linked inhibitor of apoptosis protein and relieves its inhibition of caspase-9 (Suzuki et al., 2001; Hegde et al., 2002) . In addition, Omi can promote apoptosis in a caspase-independent mechanism through its ability to function as a serine protease (Suzuki et al., 2001; Hegde et al., 2002; Martins et al., 2002; Verhagen et al., 2002) . Omi belongs to a family of mammalian proteases consisting of two members, the other being L56/HtrA1, a serine protease that is overexpressed in osteoathritic cartilage (Hu et al., 1998) , which was also repressed in fibroblasts following SV40 infection (Zumbrunn and Trueb, 1996) . The similarity between both proteins is restricted to the carboxy-terminus, which includes the proteolytic domain and a PDZ motif, while the aminoterminus of the two proteins is different (Faccio et al., 2000b) . Furthermore, while Omi is intracellular, L56/ HtrA1 is secreted (Hu et al., 1998; Faccio et al., 2000b) .
Omi is made as a precursor protein and is processed by the removal of 133 amino terminal amino acids to produce the mature protein consisting of the catalytic domain and a PDZ motif (Suzuki et al., 2001; Hegde et al., 2002; Martins et al., 2002; Verhagen et al., 2002) . PDZ domains are protein modules defined by a unique sequence of 80-100 amino acids able to recognize specific C-terminal sequences in target proteins (Saras and Heldin, 1996; Songyang et al., 1997) . They are named after the three proteins where they were originally found: postsynaptic density protein-95 (PSD-95) (Cho et al., 1992) , Drosophila discs large tumor suppressor (Dlg) (Woods and Bryant, 1991) , and the tight junction protein (ZO-1) (Itoh et al., 1993) . PDZ proteins are commonly involved in assembling large protein complexes into signaling networks; for a recent review, see Sheng and Sala (2001) . Known PDZ domains are grouped into four classes based on their binding specificity (Levchenko et al., 1997; Bezprozvanny and Maximov, 2001; Vaccaro et al., 2001) . The PDZ domain of Omi (PDZ Omi ) is unique both in amino-acid sequence as well as binding specificity. Figure 1a compares the amino-acid sequence of PDZ Omi with that of the other known PDZ domains. The only known interactor of PDZ Omi is the Mxi2 protein, an alternatively spliced form of SAPK (Faccio et al., 2000b) . PDZ Omi binds the carboxy-terminus of Mxi2 protein that is different from the consensus sequences recognized by the other families of PDZ domains (Figure 1b) . To further investigate the structural characteristics of the PDZ Omi domain, its amino-acid sequence was randomly mutated and mutant domains (PDZ m ) with altered specificity were selected. The altered specificity in this case defines the ability of PDZ m domains to bind the carboxy-terminus of the human c-Myc oncoprotein. Myc protein plays a major role in cell growth, differentiation, apoptosis and cell transformation (Littlewood and Evan, 1990; Evan et al., 1994) . Therefore, interfering with its function could have a major effect on the fate of cells. Through this screening, several Myc-specific PDZ m domains were isolated and characterized. One such Myc-specific PDZ mutant (PDZ-M1) was selected for further analysis. PDZ-M1, when expressed in mammalian cells fused to a nuclear localization signal (Kalderon et al., 1984) , was able to bind a truncated cytoplasmic form of Myc protein ) and efficiently translocate it to the cell nucleus. Furthermore, the PDZ-M1 domain colocalized with endogenous Myc protein. This specific targeting of Myc resulted in increased and significant apoptosis of the transiently transfected cells. Using c-myc null fibroblasts, we found the ability of PDZ-M1 domain to induce apoptosis was entirely dependent on the presence of Myc protein. In conclusion, our studies define the PDZ of Omi, originally identified by its similarity with other known PDZ domains, as a true functional domain. Furthermore, this work clearly shows that the basic structure of the PDZ Omi is flexible and can be exploited to engineer PDZ m domains with predetermined specificity. These PDZ m binding domains can provide a novel way to target specifically oncogenes such as Myc, in an attempt to control the fate of cells. Designed PDZ m domains linked together in tandem can also provide a biological scaffold on which to assemble specific multiprotein complexes (biological motors) that can perform specific tasks within cells.
Results

Isolation of PDZ m with altered specificity
A population of 7.5 Â 10 5 random PDZ m mutants was constructed in the yeast pJG4-5 vector. The complexity and heterogeneity of this library was verified by sequencing several randomly isolated clones. This library of mutant PDZ domains was screened using a modified yeast two-hybrid system to isolate clones encoding domains that could bind the Myc 282-439 C-terminus. This screen yielded 21 possible interactors and further analysis showed that 15 of these were true positives. Their DNA sequence was determined and grouped into six distinct families (Figure 2) .
Characterization of the PDZ m domains
To verify the selected PDZ m domains interacted with the C-terminus of Myc 282-439 and not somewhere else on the bait, a member from each family was tested for interaction against the Myc 282-437 bait lacking the last three amino acids (Myc D3). Additionally, they were tested against Mxi2 to determine if they had lost their original specificity. The results of these experiments are shown in Figure 3a . Figure 3b shows results from experiments to test the specificity of PDZ-M1 using other known members of the Myc network of proteins including N-Myc, Max and Mxi1 proteins (Zervos et al., 1993) .
Liquid assays for b-galactosidase activity (Schneider et al., 1996) were used to measure the strength of the interaction between the bait and prey proteins for each yeast clone (Table 1 ). The PDZ-M1 domain shows the strongest and most specific interaction with Myc 282-439 and has lost the ability to bind Mxi2. PDZ-M1 has two amino-acid substitutions: G 390 -V, located between b B and b C strands, and R 408 -W, present between the a A and b D . PDZ-M5 with only one of the amino-acid substitutions, G 390 -V, shows the same strong binding with Myc 282-439 bait seen with PDZ-M1, but, unlike PDZ-M1, retains some of its binding ability for Mxi2. PDZ-M6 has two amino-acid substitutions located in the same positions as PDZ-M1 and one of them is the same, R 408 -W, whereas the other introduces a different amino acid, G 390 -S. PDZ-M6 binds strongly to Myc 282-439 , but also interacts weakly with both Mxi2 and Myc D3. PDZ-M4 also has two amino-acid substitutions: Q 422 -H found between b D and b E ; E 458 -G, which is the last amino acid of PDZ Omi , and shows weak binding with Myc 282-439 . PDZ-M3 has four amino-acid substitutions: two of them are present in the two positions, 390 and 408, also found in other families (G 390 -V, R 408 -L), and the other two are in different locations P 381 -L and V 439 -A. PDZ-M3 also shows weak binding to Myc . PDZ-M2 has five mutations G 390 -V, L 392 -F, K 395 -T, T 457 -K, E 458 -N and binds weakly to both Myc 282-439 and Myc D3.
Interaction of PDZ-M1 with Myc 282-439 in mammalian cells
The PDZ-M1 domain that recognizes Myc 282-439 was cloned into pEGFP-C1 (Clontech) mammalian expression vector. This vector when transfected into mammalian cells expresses the PDZ-M1 domain as a fusion to the green fluorescent protein (GFP). A nuclear localiza-
b Figure 1 (a) Sequence alignment of the different classes of known PDZ domains. Several members from each class are aligned to indicate the conservation of amino acids in particular positions. Class I has the most members. Omi is shown together with L56/HtrA1 based on the high similarity of their respective PDZ domains. a-Helices are shown as cylinders; the amino acids responsible for the secondary structures are highlighted in blue color. PSD95-3 (residues 309-393), PSD95-2 (residues 156-246), PSD95-1 (residues 61-151) are all from PSD95 (Cho et al., 1992) ; DLG is the discs large repeat 3 (residues 482-566) (Woods and Bryant, 1991) ; hDLG is the human homolog of the Drosophila DLG (residues 460-546) (Lue et al., 1994) ; ZO1 is repeat 2 of the tight junction protein (residues 408-491) (Willott et al., 1993) ; ZO2 is a homolog of ZO1 (residues 93-176) (Jesaitis and Goodenough, 1994); Sap97 is repeat 3 of a novel pre-synaptic protein homologous to SAP90 and the Drosophila discs large tumor suppressor protein (residues 461-545) (Muller et al., 1995) ; Lin 2a is a member of the MAGUK family of cell junction proteins (residues 542-628) (Hoskins et al., 1996) ; TorSyn is a torpedo syntrophin protein (residues 65-152) (Adams et al., 1993) . hCASK binds to the heparan sulfate proteoglycan syndecan-2 (Daniels et al., 1998) ; p55 is the palmitoylated erythrocyte membrane protein (residues 67-153) (Ruff et al., 1991) . nNOS is nitric oxide synthase (residues 12-100) (Bredt et al., 1991; Riefler et al., 2001) . hINADL-3 is a human homolog to Drosophila INAD (Vaccaro et al., 2001 (Kalderon et al., 1984) was also added to target the PDZ-M1 fusion protein to the cell nucleus. The Myc 282-439 was instead cloned into the pDsRed1-C1 vector (Clontech), which fuses a red fluorescent protein (RFP) to the N-terminus of Myc 282-439 . HeLa cells were transiently transfected with both of these constructs or the parental vectors as control. After 24 h, the subcellular localization of the fluorescent fusion proteins was observed using a confocal microscope. Figure 4 , panel a1 shows the localization of the GFP-NLS-PDZ-M1 protein to be, as expected, exclusively nuclear. Panel b1 shows the DsRed-Myc 282-439 to be present in the cytoplasm of the transfected cells. Although Myc is a nuclear oncoprotein, the carboxy-terminal part of the protein (Myc 282-439 ) used as bait in our experiments lacks the nuclear localization signals that are present in the N-terminus of Myc (Stone et al., 1987) . Panel c1 shows HeLa cells cotransfected with both constructs; DsRed-Myc 282-439 is now present in the cell nucleus where it colocalized with the GFP-NLS-PDZ-M1.
Interaction of PDZ-M1 with endogenous full-length Myc protein
GFP-PDZ-M1 and a specific anti-Myc antibody (Santa Cruz Biotechnology) that binds to the amino terminus of the Myc protein (aa 1-262) were used to detect interaction between PDZ-M1 and endogenous Myc protein. This antibody was selected because it cannot interfere with any protein-protein interaction that occurs at the carboxy-terminus of the protein. 
Semiquantitative representation of the strength and specificity of binding between the different PDZ m domains and their targets. Results were compiled from several independent yeast experiments that measured b-galactosidase activity (Schneider et al., 1996) .
Specific targeting of Myc proto-oncogene D Junqueira et al
The PDZ-M1 promotes apoptosis in mammalian cells
The carboxyl terminus of Myc is essential for its ability to bind to the Max protein and for these heterodimers to bind to DNA (Blackwood et al., 1992; Solomon et al., 1993; Grandori et al., 1996) . Therefore, overexpression of the PDZ-M1 in transiently transfected cells might interfere with the normal function of Myc. Flow cytometry and annexin V probe (BD Biosciences) were used to investigate whether HeLa cells expressing the PDZ-M1 exhibited increased apoptosis. 
Discussion
Omi/HtrA2 is a serine protease isolated originally as an interactor of Mxi2 kinase (Faccio et al., 2000b) . The mature Omi protein consists of a catalytic domain as well as a PDZ motif. Its amino-acid sequence has been conserved from bacteria to humans (Faccio et al., 2000b) . There is 36% identity and 58% similarity in the amino-acid sequence between bacterial HtrA and mature human Omi protein (Faccio et al., 2000b) . Bacterial HtrA is a chaperone at normal temperatures and an active protease at elevated temperatures that can cleave and remove denatured or damaged proteins leading to the survival of bacteria (Spiess et al., 1999; Krojer et al., 2002) . There is also a mammalian homolog of Omi called L56/HtrA1 (Zumbrunn and Trueb, 1996; Hu et al., 1998) , which has 52% identity and 72% similarity with mature Omi. The highest similarity between these two proteins is found in their catalytic domains, which share 61% identity and 80% similarity. There is less similarity in the PDZ domains of Omi and L56/HtrA1, which share 40% identity and 62% similarity. Bacterial HtrA has two PDZ domains that are necessary for multimerization of the enzyme as well as binding to its substrates (Fanning and Anderson, 1996; Hung and Sheng, 2001 (Faccio et al., 2000c) . D-Omi is an inactive protease, has a modified PDZ domain and its physiological function in these tissues is unknown (Faccio et al., 2000c) . Figure 1 shows an alignment of the amino-acid sequence of the five classes of PDZ domains performed using the Clustal W program (Aiyar, 2000) . The secondary characteristic elements defining PDZ domains, derived from X-ray crystallographic studies, are highlighted. Secondary structure motifs of the PDZ Omi were predicted using homology modeling software and the PDZ-3 of PSD-95 as a template. This comparison reveals that the overall topology of the PDZ repeat is strongly conserved in all five classes. The overall structure of PDZ Omi is similar to other known PDZ domains. While it has six b-strands and two a-helices, the so-called variable loop, located between putative strands b B and b C , is slightly longer in PDZ Omi than that of the other classes of domains. As a result, the b D strand appears distorted (Hung and Sheng, 2001) . Structural studies have shown the carboxyterminal peptide (ligand) fits in the hydrophobic pocket that includes the a-helix (a B ), the second b-strand (b B ), as well as the conserved GLGF loop (Doyle et al., 1996) . This loop in PDZ Omi is represented by a different amino-acid sequence, LAEL. The PDZ Omi also differs from other families of PDZ domains, in that its variable loop between b B and b C is longer and, as a result, the b D -strand is distorted. These differences suggest the (Faccio et al., 2000b) . Mxi2 is the only known protein that specifically binds the PDZ domain of Omi. Mxi2 is an alternatively spliced form of SAPK and was used as bait in the original isolation of Omi (Faccio et al., 2000b) . The carboxyterminus of Mxi2 ends in DIELVMI amino-acid sequence and deletion of the last two amino acids completely abolish its binding with PDZ Omi (Faccio et al., 2000b) . To investigate the structural characteristics of the PDZ Omi , its amino-acid sequence was randomly mutated and the pool of mutants was screened for a PDZ m with altered binding specificity. In this case, the pool was screened for the ability to bind the carboxy-terminus of Myc (Myc 282-439 ). Myc is a nuclear oncoprotein involved in cell growth, apoptosis, differentiation and cell transformation (Littlewood and Evan, 1990; Evan et al., 1994) . The carboxy-terminus of Myc ends in the amino-acid sequence LRNSCA that is substantially different from the Mxi2 carboxy-terminus that ends in DIELVMI. Myc protein does not bind the wild-type PDZ Omi . Using a yeast two-hybrid screen, we were able to obtain PDZ m domains that could bind Myc 282-439 . These PDZ m domains were grouped into six families based on their binding strength and specificity. Some of them bound to Myc 282-439 but also retained the ability to bind weakly to Mxi2. Others bound to Myc 282-439 but also bound to the MycD3, indicating that they recognized amino acids outside the extreme carboxyterminus of the Myc protein. Several PDZ m proteins showed strong and specific binding with Myc 282-439 . When the amino-acid sequence of the different PDZ m was deduced, most of the mutations were found clustered at positions 390 and 408 of the PDZ domain. Amino acids in these two positions were invariably changed to be hydrophobic. One family of PDZ m (PDZ-M1) that exhibited strong and specific binding with Myc 282-439 was selected for further investigation. This family had a Gly 390 -Val and Arg 408 -Trp substitution in its PDZ domain. Both amino-acid substitutions were necessary for changing the specificity of the PDZ Omi because another PDZ m family that only differed in a single position, (Gly 390 -Val), showed binding to both Myc and Mxi2. Furthermore, the ability of PDZ-M1 to bind to the Myc 282-439 bait protein in mammalian cells was also investigated. Myc is a nuclear protein, but Myc 282-439 used in our experiments is cytoplasmic because it lacks the nuclear localization signals that are located in the amino terminus of the protein (Stone et al., 1987) . We therefore expressed the PDZ-M1 specific for Myc 282-439 with a strong nuclear localization sequence fused to the GFP. The Myc 282-439 bait was also expressed fused to the RFP. When both PDZ-M1 and Myc 282-439 were coexpressed in mammalian cells, PDZ-M1 was able to bind to and translocate Myc 282-439 to the cell nucleus. Whether, the PDZ-M1 domain could also bind to the endogenous Myc protein and interfere with its normal function was further investigated. PDZ-M1 was expressed in transiently transfected mammalian cells and found to colocalize with endogenous Myc protein. Furthermore, the same cells transfected with PDZ-M1 exhibited increased apoptosis compared with cells transfected with a control PDZ Omi , domain that does not bind to Myc. To further establish that the PDZ-M1-induced apoptosis is the result of a specific interaction with endogenous Myc protein, we used c-Myc deficient fibroblasts (HO15.19). These cells when transfected with PDZ-M1 were resistant to apoptosis. When c-myc expression was reconstituted in these cells (HO/myc3) they reverted back to being sensitive to PDZ-M1-induced apoptosis. These results clearly demonstrate that the ability of PDZ-M1 to induce apoptosis is entirely dependent on its interaction with Myc protein. Furthermore, PDZ-M1 by binding the carboxyl terminus of Myc interferes with the normal function of this protein driving cells to apoptosis. This is the first report of a PDZ domain used to target and modify the activity of Myc protein.
Our data indicate that the PDZ domain of Omi can be used as a prototype to develop artificial PDZ domains able to target cellular proteins. In a similar approach, the PDZ domain of the Ras-binding protein AF-6 was used as a prototype to develop PDZ mutants able to bind new protein targets (Schneider et al., 1999; Gee et al., 2000) . For successful interaction to occur, the carboxy-terminus of the target proteins, recognized by the PDZ domains, must be exposed and available for binding. These artificial PDZ domains can provide scaffolds for the development of specific multi-protein complexes. They can easily be used to target, translocate, inhibit or enhance the normal function of numerous cellular proteins, thus providing information on the normal function of proteins and their potential role in human disease. Finally, artificial PDZ domains can also be used as therapeutic agents to target and modulate the activity of oncogenes such as the Myc proto-oncogene used in the experiments reported here.
Materials and methods
Yeast two-hybrid experiments
EGY48 (MATa trp1 ura3 his3 LEU2::pLex Aop6-LEU2) was used as the host yeast strain for all two-hybrid interaction experiments . This yeast strain has both an integrated LEU reporter gene with upstream LexA operators, as well as a pSH18-34 (LexAop-lacZ) 2m plasmid that directs the synthesis of b-galactosidase . Positive protein-protein interactions between the bait and prey were initially detected by the ability of the yeast to grow on GALUra-Trp-His-Leu-selective yeast plates. They were further tested on Ura-His-Trp-X-gal plates. Plasmids were rescued from positive clones and introduced into KC8 E. coli by electroporation. DNA sequence was determined by sequencing both DNA strands with a commercially available kit (PE Applied Biosystems) using an ABI Prism 310 Genetic Analyzer (Perkin-Elmer). The presence and stability of the recombinant proteins in yeast cells was monitored by Western blot analysis using either LexA (for baits) or HA-antibodies (for preys).
Generation of PDZ m
Random mutations in the PDZ Omi (between amino acids 335 and 458) were introduced using PCR reactions and the following primers: Primer A (5 0 -end): 5 0 -GATGTCCCAGAT-TATGCCTCTCCCGAATTCTCTGATCGTCTTCGAGAG TTT-3 0 . Primer B (3 0 -end): 5 0 -CTCTGGCGAAGAAGTCCA AAGCTTCTCGAGTCATTCTGTGACCTCAGGGGT-3 0 A DNA polymerase was used that is prone to errors when copying DNA (Mutazyme, Stratagene). To increase the mutation frequency, four sequential PCR reactions were performed, in which the product of the first reaction was diluted 1 : 1000 in TE buffer and used as the template for the following reaction. All four PCR reactions were combined, the DNA was digested with MfeI/XhoI and cloned into the EcoRI/ XhoI of the pJG4-5 vector (Fusco et al., 1999) . This DNA was used to transform yeast that already contained a bait representing the C-terminus of Myc (aa 282-439) cloned in the pL202 expression vector. A population of 7.5 Â 10 5 independent yeast clones were screened as described (Zervos et al., 1993) .
Construction of c-MycD3 deletion mutants
The following primers were used in a PCR reaction: Primer C (5 0 -end):
0 . Primer D introduces a stop codon (TAA) at position 1310 (aa 437) in the Myc sequence. This truncated form of Myc lacks the last three C-terminal amino acids. After the PCR, the DNA fragment was digested EcoRI/BamHI and cloned into the corresponding sites of the pL202 yeast vector. The specificity of the different PDZ m domains against LexAMycD3aa, LexA-Mxi2 and LexA-Myc 282-439 was determined using standard yeast two-hybrid methodologies (Zervos et al., 1993; Fusco et al., 1999) .
Construction of LexA-N-myc, Max and Mxi1 baits
The following primers were used in a PCR reaction for cloning of N-myc c-terminal (aa 236-394) and Max full length: Primer E (N-myc 5 0 -end):
The PCR products were digested with EcoRI/BamHI and cloned into the corresponding sites of the pL202 yeast bait vector. LexA-Mxi1 has been previously described (Zervos et al., 1993) .
Mammalian expression of recombinant proteins
The following primers were used to PCR the DNA fragments corresponding to wild-type PDZ Omi and PDZ-M1 from yeast vectors: Primer I (5 0 -end): 5 0 -CCGCTCGAGCGCCTC-CAAAAAAGAAGAGAAAGGTAGCTT CTGATCGTCT-TCGAGAGTTTC-3 0 . Primer J (3 0 -end): 5 0 -CGGGGTACCT-CATTCTGTGACCTCAGGGG-3 0 . Primer I includes the DNA sequence (underlined) that encodes the SV40 NLS, PPKKKRKVA (Kalderon et al., 1984) in frame with the PDZ domain. The PCR products were digested with XhoI/KpnI and cloned in the corresponding sites of pEGFP-C1 vector (Clontech).
The Myc C-terminus DNA sequence corresponding to aa 282-439 was amplified using the following PCR primers:
0 . The PCR product was digested with EcoRI/ BamHI and cloned in the corresponding sites of pDsRed1-C1 vector (Clontech).
In a different set of experiments, DNA corresponding to wild-type PDZ Omi or PDZ-M1 without the NLS was amplified using the following primers: Primer M (5 0 end) 5 0 -CGGAATTCTTCTGATCGTCTTCGAGAGTTTC-3 0 . Primer N (3 0 end) 5 0 -CGGGGTACCTCATTCTGTGACCT-CAGGGG-3 0 . The PCR products were precipitated, digested with EcoRI and KpnI, and cloned to the corresponding sites of pEGFP-C1 vector (Clontech).
Cell lines and culture conditions
HeLa cells were grown using F12-Nutrient mixture (HAM) media (Life Technologies) supplemented with 10% FCS (Sigma), 2 mm l-glutamine, 100 U/ml penicillin and 100 mg/ ml streptomycin (Life Technologies). TGR-1 (c-myc+/+), HO15.19 (c-mycÀ/À homozygous knockout) and HO/myc3 (HO15.19 cells infected with a retrovirus vector expressing cmyc) were grown in DMEM (GIBCO) supplemented with 2 mm L-glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin, 1 mm sodium pyruvate (Sigma).
Transfections and immunofluorescence microscopy
For immunofluorescence, the cells were grown on cover slips. Approximately, 70% confluent cells were transfected with 2 mg of GFP-NLS-PDZ Omi and RFP-Myc 282-439 using Lipofectamine Plus reagent according to the instructions provided by the manufacturer (Life Technologies). After 24 h, the transfected cells were washed three times with PBS and fixed with 4% paraformaldehyde. The coverslips were then placed on glass slides using Fluoromount-G solution (Southern Biochemical Association). The subcellular localization of GFP-and RFP-tagged proteins was monitored using a LSM510 confocal laser-scanning microscope (Carl Zeiss).
Western blot analysis
Transiently transfected cells were lysed using a Triton X-100 based lysis buffer (1% Triton X-100, 10% glycerol, 150 mm NaCl, 20 mm tris pH 7.5, 2 mm EDTA) in the presence of a protease inhibitor mix (Roche). Approximately, 20 mg of whole-cell extracts were resuspended in SDS-sample buffer and boiled for 3 min. The samples were resolved by SDS-polyacrylamide gel electrophoresis (PAGE) and electro-transferred onto PVDF membranes (NEN Life Science products) using a Semi-Dry cell Transfer Blot (Bio-Rad). Nonfat dry milk (2%) in TBST buffer was used to block nonspecific binding of the membrane. The membrane was incubated with an anti-GFP monoclonal antibody (Santa Cruz Biotechnology), 1 : 700 dilution, followed by a secondary peroxidase-conjugated goat anti-mouse (Jackson ImmunoResearch) 1 : 15000 dilution and visualized by ECL (Pierce).
Flow cytometry
HeLa, TGR-1, HO15.19, HO/myc3 cells were grown in six-well plates to 60% confluence and were transfected with EGFPC1 vector, GFP-PDZ Omi or GFP-PDZ-M1 using Lipofectamine Plus Reagent according to the instructions provided by the manufacturer (Life Technologies). Transfected cells were detached 48 h later using 0.02% EDTA (Sigma), washed twice with ice-cold PBS, resuspended 
